Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
ST Herbst 2022 der DGNC
Programm
Personen
Suche
EN
Alle Personen
Michael Sabel
Düsseldorf
Sortiert nach Typ
Datum
Vorsitz
27.10.2022
14:45
–
15:45
Sektion Neuroonkologie
Molekulare Diagnostik und Therapie I
Saal A
28.10.2022
09:45
–
10:45
Joint Session
Joint Session Neuroonkologie und Technik & Innovation – Intraoperatives Neuromonitoring und Mapping
Saal B
28.10.2022
13:45
–
14:30
Sektion Neuroonkologie
Study Break
Saal B
Weitere Beteiligungen
27.10.2022
14:45
–
14:55
7 Min.
3 Min.
Abstractvortrag
Establishment of Cell Culture Models from Intracerebral Carcinoma Metastases for Personalized Preclinical Evaluation of Novel Therapeutic Approaches
27.10.2022
14:55
–
15:05
7 Min.
3 Min.
Abstractvortrag
In-Vitro Use of Verteporfin for Photodynamic Therapy in Glioblastoma
27.10.2022
16:45
–
16:55
7 Min.
3 Min.
Abstractvortrag
Comparison of epidural and cortical motor mapping in eloquent brain tumours
27.10.2022
16:55
–
17:05
7 Min.
3 Min.
Abstractvortrag
60 Hz bipolar stimulation for identification of M1 in patients with eloquent cerebral lesions
28.10.2022
09:45
–
09:55
7 Min.
3 Min.
Abstractvortrag
Analysis of influence of cortex temperature on patient cognition during awake-surgery – A pilot study
28.10.2022
09:55
–
10:05
7 Min.
3 Min.
Abstractvortrag
Feasability of intraoperative neuromonitoring and cortical/subcortical brain mapping in patients with eloquent cerebral lesions of several localizations- pathway to case adapted monitoring procedures
28.10.2022
10:05
–
10:15
7 Min.
3 Min.
Abstractvortrag
Monopolar and bipolar brain mapping during brain surgery beyond standard IONM settings
28.10.2022
11:15
–
11:25
7 Min.
3 Min.
Abstractvortrag
Case Report: Disruption of Resting-State Networks and Cognitive Deficits After Whole Brain Irradiation for Singular Brain Metastasis
28.10.2022
11:55
–
12:05
7 Min.
3 Min.
Abstractvortrag
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy – the MecMeth/NOA-24 trial study protocol
28.10.2022
16:05
–
16:15
7 Min.
3 Min.
Abstractvortrag
Analysis of using a thermal imaging camera to detect superficial brain tumors – a pilot study
28.10.2022
16:15
–
16:25
7 Min.
3 Min.
Abstractvortrag
Quantification of PpIX-fluorescence of cerebral breast cancer metastases
29.10.2022
09:10
–
09:20
7 Min.
3 Min.
Abstractvortrag
Prognostic impact of obesity in newly-diagnosed glioblastoma: A secondary analysis of CeTeG/NOA-09 and GLARIUS
29.10.2022
12:00
–
12:10
7 Min.
3 Min.
Abstractvortrag
The impact of neuropathological diagnosis on psycho-oncological distress and the quality of life in glioma patients
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz